Tiziana Life Sciences (TILS)

 

TILS Share PerformanceMore

52 week high240.00 25/04/17
52 week low102.05 08/06/17
52 week change 25.00 (16.95%)
4 week volume70,327 02/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Appointment of Dr Kunwar Shailubhai as CEO

Miscellaneous medium priority announcements

NOTIFICATION OF MAJOR INTEREST IN SHARES

RNS Number: 5387H Tiziana Life Sciences PLC 08 June 2017 T R -1: N O T I F IC A T I ONOF M A JORI NT E R ESTINSH A RE S i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii TIZIANA LIFE SCIENCES PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal ...

Bcl-3 pre-clinical update and Director's dealing

RNS Number: 5190H Tiziana Life Sciences PLC 08 June 2017 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION Tiziana Life Sciences plc ("Tiziana" or "the Company") Bcl-3 pre-clinical development programme update and Director's dealing London, 8 June 2017 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), a clinical stage biotechnology company...

2016 Annual Report and Accounts and notice of AGM

RNS Number: 7524G Tiziana Life Sciences PLC 01 June 2017 Tiziana Life Sciences plc ("Tiziana" or "the Company") 2016 Annual Report and Accounts and notice of Annual General Meeting London, 01 June 2017 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, t...

Financial Results for Year Ended 31 December 2016

RNS Number: 8921F Tiziana Life Sciences PLC 23 May 2017 Tiziana Life Sciences plc ("Tiziana" or "the Company") Financial Results for the Year Ended 31 December 2016 Strong progress continues across clinical and pre-clinical programmes London, 23 May 2017 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), a clinical stage biotechnology company developing ta...

Broker Forecast - Beaufort Securities issues a broker note on Tiziana Life Sciences Plc Ord 3p

Beaufort Securities today reaffirms its speculative buy investment rating on Tiziana Life Sciences Plc Ord 3p (LON:TILS) ...

TILS confirms Phase II clinical trial protocol for Milciclib

Tiziana Life Sciences has announced the approval in Israel of a phase II clinical trial protocol for testing milciclib, a novel ...

Announces Approval of a Phase II Clinical Trial

RNS Number: 0864D Tiziana Life Sciences PLC 24 April 2017 Tiziana Life Sciences plc ("Tiziana" or the "Company") Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib in Patients with Hepatocellular Carcinoma In mouse models of HCC, oral administration with milciclib effectively suppressed tumour growth London, 24 A...

Fundamental DataMore

EPS-7.7
Dividend yield0 %

Equity Research (TILS)

equity development
Tiziana Life Sciences PLC
26/01/2015
TILS has just announced an exclusive license with Nerviano Medical Sciences (NMS) for its Phase 2 anti-cancer drug candidate, milciclib. It helps block the rampant cell division associated with...
equity development
Tiziana Life Sciences PLC
12/01/2015
Tiziana (TILS) and Novimmune S.A., a company focused on the discovery and development of antibody-based drugs to benefit patients with inflammatory, auto-immune disorders, and cancer, have announced...
equity development
Tiziana Life Sciences PLC
30/09/2014
Tiziana Life Sciences (TILS) has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment,...

Latest discussion posts More

  • Top up

    Bad news this am but couldn't resist a 500 top up at 115.06.
    8-Jun-2017
    osammyboy
  • Fundraise

    Beaufort Securities's note out this morning on Research Tree: "Tiziana progressed well during the FY2015. It strengthened its portfolio by acquiring exclusive licence for both ...
    8-Jun-2016
    Simbr
  • no buying

    With sp @110 and bid @ 115 I tried buying 2500 online at Barclays. Quoted 187.4 Obviously buying is being discouraged for whatever reason
    28-Apr-2016
    osammyboy

Users' HoldingsMore

Users who hold Tiziana Life Sciences also hold..
ID:ISIN:GB00B474YB1263%
LLOYDS GRP.29%
ROYAL BANK SCOT18%
TAYLOR WIMPEY15%
AVIVA13%

Codes & Symbols

ISINGB00BKWNZY55
SymbolsTILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS